Mizuho Securities Upgrades Biogen (BIIB) to Buy
Tweet Send to a Friend
Mizuho Securities upgraded Biogen (NASDAQ: BIIB) from Neutral to Buy with a price target of $400.00 (from $319.00).Analyst Salim Syed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE